Home Blog Page 552

Overwhelmed Mental Health Care Workers Demonstrate Need for New Ways to Provide Care

0
Overwhelmed Mental Health Care Workers Demonstrate Need for New Ways to Provide Care
ADHD Online alleviates overburdened system's long wait times for patients to receive ADHD assessments, treatments, and care

GRAND RAPIDS, Mich. - September 7, 2022 - (Newswire.com)

An ongoing strike by mental health workers, coupled with state laws that mandate urgent responses to mental health issues, highlight the need for expanded resources for mental health care such as the assessment, diagnosis and treatment services provided by ADHD Online.

Recent events in California highlight a looming national problem. A new state law, passed in 2021, mandates that mental health providers respond quickly to requests for mental health care - including offering appointments within 10 business days. Psychologists, therapists and other mental health professionals say they are stretched too thinly, prompting the strike.

Those resource constraints force routine procedures like ADHD assessments to be treated as low priority, creating months-long wait times for assessments. Strikes by mental health push out ADHD assessment appointments even further, past 12 months in most cases, according to ADHD Online. And that places tremendous stress on individuals and families.

"Because ADHD assessments are not considered urgent, a family member may be waiting far too long to get answers and start living a better life," said Zachariah Booker, CEO and co-founder of ADHD Online. "If you've had that experience, you know that you can't get answers quickly enough."

ADHD Online, founded in 2018, alleviates the burden on traditional mental health services through its system of HIPAA-secured, online ADHD assessments that connect people with licensed, doctoral-level psychologists who can perform ADHD assessments within three to five days.

ADHD Online's certified assessments and any resulting diagnoses can be taken to patients' own primary care providers for treatment, or the patient can use ADHD Online's network of providers for ongoing treatment. In select states, ADHD Online also offers streamlined teletherapy appointments with master-level clinicians over HIPAA-compliant Zoom accounts.

"We know that the mental health care system is overburdened and that people need better ways to get the care they need," Booker said. "Our mission is to ensure that everyone should have access to quality ADHD assessments regardless of who and where they are, and we have built a team of licensed professionals who are passionate about providing that care."

ADHD Online is the only organization to offer HIPAA-secured ADHD assessments online with certified results from licensed psychologists. After diagnosis, ADHD Online providers and patients develop an ADHD treatment plan which may include medication and therapy, but the company does not advocate for treating all patients with medication and has no relationships with pharmaceutical companies.

For any patients beginning medication, ADHD Online requires an initial 30-day follow-up visit and repeated 90-day follow-ups if the patient is stable on their medications. Patients also provide their vital signs to ADHD Online throughout their care. 

Please visit https://adhdonline.com for more information.

About ADHD Online

ADHD Online was founded in 2018 with the mission that everyone should have access to quality ADHD assessments regardless of who and where they are. The ADHD Online team is filled with industry experts across the United States who all share the same passion for ADHD and making sure patients have access to critical mental health services. ADHD Online is leading the way with being a critical voice for those who might be struggling with ADHD and is the only organization to offer HIPAA-secured ADHD assessments online with certified results from licensed psychologists. ADHD Online is active in all 50 states.

Media Contact

Dan Johnson
[email protected]




Press Release Service by Newswire.com

Original Source: Overwhelmed Mental Health Care Workers Demonstrate Need for New Ways to Provide Care

The QUID-NASH Research Consortium (Paris, France) and PharmaNest, Inc. (Princeton, USA) Enter a Strategic Partnership for the Study of NASH

0
The QUID-NASH Research Consortium (Paris, France) and PharmaNest, Inc. (Princeton, USA) Enter a Strategic Partnership for the Study of NASH
The QUID-NASH Research Consortium (Paris, France) and PharmaNest, Inc. (Princeton, USA) enter a strategic partnership to use artificial intelligence (AI) powered tool for the diagnosis and staging of NASH (non-Alcoholic Steatohepatitis) in patients with type 2 diabetes (T2D).


FibroNest's AI scores Fibrosis Severity in Liver Biopsies

Liver Biopsies in three different stages of fibrosis severity are automatically scored by Fibronest with reproducibility and detection thresholds that exceed current methods

PARIS - September 7, 2022 - (Newswire.com)

The QUID-NASH Research Consortium (Paris, France) and PharmaNest, Inc. (Princeton, USA) announced today that they have entered a strategic partnership that will support the development and validation of a virtual liver biopsy (non-invasive) and artificial intelligence (AI)-powered tool for the diagnosis and staging of NASH (Non-Alcoholic Steatohepatitis) in patients with type 2 diabetes (T2D).

The clinical study involves 600 type 2 diabetic patients who are receiving a liver biopsy as part of standard care. The data collected (imaging, deep clinico-biological phenotyping, different omic approaches, extracellular vesicles and immune blood cell profiling) will be analyzed with the Swiss Institute of Bioinformatics (SIB) and Bichat biostatistical teams through comprehensive and deep bioinformatics and biostatistics. 

Through its cloud-based, Digital Pathology platform FibroNest, PharmaNest will generate single-fiber and single-nuclei high-content quantitative histological datasets from each digital biopsy image to generate continuous scores that quantify the phenotypes of fibrosis and stage the severity of fibrosis and disease activity of NASH. This dataset will enrich the data collected and enable the consortium to discover novel histological phenotypes of NASH in T2D  patients.

"The quantitative FibroNest method resolves the limitation of the current categorical and semi-quantitative methods and paradigms used of the histological assessment of liver biopsies," says Prof. Valerie Paradis, Chair of the Pathology Department at Beaujon Hospital and leader of the INSERM team.

"PharmaNest is excited to enable the QUID NASH consortium to enter the research field of Pathomic-Fusion and provide a robust and automated method for the quantification of the fibrosis," says Mathieu Petitjean, Ph.D., CEO of PharmaNest, Inc. 

"The addition of FibroNest's Digital Pathology and Artificial intelligence capabilities to the QUID-NASH consortium will enhance performance of our upcoming virtual biopsy tests and generate significant upside for the investigation and understanding of NASH in T2D patients," says Pr. Dominique Valla, Principal Investigator and founding director of the French Reference Center for Vascular Diseases of the Liver

About QUID-NASH

The QUID-NASH research program is a clinical research consortium that includes Assistance Publique-Hôpitaux de Paris, Universities Paris-Descartes and Paris-Diderot, Commissariat à l'Energie Atomique (CEA), Laboratoires Servier and BioPredictive which operate under the leadership of the National Institute of Health and Medical Research (INSERM) of France. Clinical sites and teams include diabetology in Lariboisière and Cochin hospitals, Hepatology in Beaujon and Cochin, Imaging in Necker Beaujon and Physics for Medecine Paris. 

About PharmaNest

PharmaNest is a Digital Pathology and Artificial Intelligence company focused on the development and validation of novel histological standards for the quantification of Inflammation and fibrosis. Its multivendor platform, FibroNest, is delivered worldwide via the cloud and used in multiple pre-clinical and clinical studies across several fibrotic conditions.

For more information about FibroNest and PharmaNest, visit www.pharmanest.com and www.fibronest.com

Media Contact

Mathieu M. Petitjean, Ph.D.

CEO, PharmaNest

E: [email protected]




Press Release Service by Newswire.com

Original Source: The QUID-NASH Research Consortium (Paris, France) and PharmaNest, Inc. (Princeton, USA) Enter a Strategic Partnership for the Study of NASH

Addinex Technologies Awarded $260K Grant by the CDC to Improve Addiction Medication Dispensing

0
Addinex Technologies Awarded 0K Grant by the CDC to Improve Addiction Medication Dispensing
Addinex will work with Yale School of Medicine, Aware Recovery Care, and the In-Home Addiction Treatment Institute to adapt its award-winning opioid dispensing system

NEW YORK - September 7, 2022 - (Newswire.com)

Addinex Technologies, Inc., a healthcare technology company focused on the innovation of medication dispensing, has been awarded a $260K Phase I Small Business Innovation Research (SBIR) grant by the Centers for Disease Control and Prevention (CDC) to improve on existing addiction medication dispensing for people with opioid use disorder (OUD).

The grant will help fund the adaptation of Addinex's award-winning patented pill dispensing system that recently completed a successful study using opioids on post-surgical cancer patients at Columbia University Medical Center. Results of that study were recently published in the peer-reviewed journal, Cancer. The adapted dispenser will work with buprenorphine, including Suboxone®, a common form of addiction treatment medication that comes in a sublingual film, and Addinex's patient app will focus on the unique needs of people suffering from OUD. 

"9.5 million people aged 12 or older misuse opioids, representing 3.3% of that population, 2.7 million people suffer from OUD, and annual overdose deaths from opioids recently rose to over 80,000. Many patients diagnosed with OUD will be treated by a combination of buprenorphine, a schedule III narcotic, along with counseling and behavioral therapies, also known as Medication Assisted Treatment," stated Jay Schiff, Co-Founder and CEO of Addinex Technologies, Inc. "Our patented, low-cost medication dispensing system provides a cost-effective way to improve adherence and reduce diversion while educating patients about proper usage and making excess medication disposal easy. We're excited to work with a world-class team of addiction treatment providers and researchers."

"I am extremely excited about this research project and the extraordinary collaboration between the IHATI, Aware, Yale School of Medicine, and Addinex. I look forward to future research efforts," stated Jennel Fontanelle, Executive Director of the IHATI.

According to Shelley Halligan, SVP Medical Affairs, Aware Recovery Care, "This is the type of cutting-edge advancement needed in this space. Individuals with OUD recover better in the home, which allows for more autonomy and family involvement in the recovery journey. We are thrilled to partner with Addinex, Yale University, and the IHATI on this project."

About Addinex Technologies, Inc.

Addinex Technologies is a cutting-edge developer of low-cost medication dispensing systems targeting misused prescription drugs. Addinex's patented low-cost mechanical dispenser regulates usage based on each patient's unique prescription, assists doctors with prescribing based on usage data by similar patients, provides education and real-time progress feedback to patients and their doctors, and incorporates a DEA-approved mailer for easy excess pill disposal. Addinex's system was named a 2002 "World Changing Idea" by Fast Company magazine. For more information, visit Addinex at www.addinextech.com.

About Aware Recovery Care

Aware Recovery Care is a mission-driven company challenging traditional approaches to the treatment of Substance Use Disorder (SUD). A pioneer in In-Home Addiction Treatment (IHAT™), Aware delivers evidence-based, personalized service. Led by a multidisciplinary team of professionals and paraprofessionals, the unique 52-week program is designed for impact, reaching clients and their families in their own homes and communities. Aware's high-touch model improves the lives of people affected by addiction and creates irrefutable value for managed care plans and employers. Aware's outcomes clearly demonstrate that sustained recovery is achieved through deeper trust and genuine partnership. Aware operates in nine states (CT, MA, RI, NH, ME, VA, OH, IN, FL) and is poised for national expansion.

About In-Home Addiction Treatment Institute

The In-Home Addiction Treatment Institute is a registered nonprofit organization with a strong dedication to researching progressive alternatives to traditional substance abuse treatment systems. Our mission is to increase accessibility, education, and research on in-home services for substance use disorder treatment. Our goal is to provide standardized training opportunities, IHAT certifications, and innovative treatment solutions to increase the quality of services delivered in the substance use disorder population.

Contact (Addinex):
Jay Schiff, Co-Founder and CEO
Addinex Technologies, Inc.
(917) 628-8026
[email protected]

Contact (Aware/IHATI):
Peter Gold
Gold & Partners, LLC
(860) 874-7743
[email protected]




Press Release Service by Newswire.com

Original Source: Addinex Technologies Awarded $260K Grant by the CDC to Improve Addiction Medication Dispensing

332,000 Pounds of Bellamy’s Infant Milk Formula Hits US Shores to Address Formula Shortage

0
332,000 Pounds of Bellamy’s Infant Milk Formula Hits US Shores to Address Formula Shortage

Bellamy's Organic infant formula step 1 (0-6months)

image of Bellamy's Organic formula tin

DALLAS - September 7, 2022 - (Newswire.com)

Bellamy's Organic has been permitted by the Food and Drug Administration (FDA) to sell its infant milk formula in the US to help address the country's ongoing, market-wide formula shortage.

166,000 32oz (900g) tins of Bellamy's Organic baby formula (about 332 thousand pounds or 4.77 million full-sized, 8-ounce bottles) are loaded to take off from Melbourne, Australia on 7th September and arrive in Dallas, Texas soon after. 

Once the formula is cleared by US Customs, Bellamy's Organic will work with retailers to ensure products are available for American parents and carers to purchase as quickly as possible, initially via Amazon, with an extended list of retailers to follow in the coming months.  

Bellamy's Organic has been working closely with the FDA, USDA and U.S. Department of Health and Human Services (HHS) to deliver our premium formula to the USA, assisting American Moms, Dads and carers during this shortage.

Bellamy's Organic was one of less than 20 companies globally with products successfully assessed by the FDA as safe and nutritious for US infants, following applications by hundreds of suppliers to help. 

The first products available to American families are:

  • Bellamy's Organic Infant Formula Step 1 (0-6 months,) and 
  • Bellamy's Organic Follow-On Formula Step 2 (6-12 months)

Bellamy's Organic was founded in 2004 by an Aussie mother based in clean, green Tasmania, Australia. The founding mission was to make simple, tasty, nutritious infant baby formula and baby food, free from pesticides, artificial fertilisers, growth hormones, antibiotics and GMO ingredients.

Bellamy's Organic today continues to prioritise nutrition and science, with premium ingredients to deliver products formulated to meet the nutritional needs of children globally. 

Shae Rickards, Global Nutrition Manager and Paediatric Dietitian of Bellamy's Organic said, "Millions of American parents are still struggling to get their hands on safe, premium and nutritious infant formula. Bellamy's Organic is committed to assisting the US with supply at this critical time.

"Our products available in the US are made in Australia from premium ingredients," she said.

"We adhere to strict Australian food safety standards, and look forward to providing families with peace-of-mind that they are accessing a safe product," she said.

The Bellamy's Organic brand has never experienced a major recall or product safety issue.

Bellamy's Organic awaits the FDA's further guidance about how it may facilitate potential distribution and long-term supply of Bellamy's Organic Infant Formula products in the US beyond November.

For all media enquiries please contact: 

Chloe Jeffers | [email protected] | +61 401 914 522

Alexandra Brudenell | [email protected] | +61 402 442 721 

About Bellamy's Organic

At Bellamy's Organic, we pride ourselves on producing safe, wholesome and nutritious foods for babies, toddlers and children,  so that from the outset they develop mindful and healthy eating habits. Take a closer look at our credentials, story, stockists and our product range at bellamysorganic.com


Related Files
332,000 pounds of Bellamy's infant milk formula hits US shores to address formula shortage.pdf



Press Release Service by Newswire.com

Original Source: 332,000 Pounds of Bellamy's Infant Milk Formula Hits US Shores to Address Formula Shortage

KMC Controls Celebrates Employee’s 52 Year Career

0
KMC Controls Celebrates Employee’s 52 Year Career

Chris Kreuter

Chris Kreuter sitting at his desk.

NEW PARIS, Ind. - September 6, 2022 - (Newswire.com)

KMC Controls®, an industry leader in building automation, is at once delighted and saddened to announce the retirement of Chris Kreuter, an innovator whose career spanned more than 50 years with the company. 

Chris' career started 52 years ago when his father, Ken Kreuter, founded Kreuter Manufacturing - today called KMC Controls.

In the late-1960s Ken realized an opportunity to form his own company. "My dad wanted to design a line of controls of our own," explained Chris, "and that's what we started doing. We built molds and dies to make our own parts and our own controls."

At the company's inception, Chris worked in partnership with his father, two of his brothers, and future brother-in-law. "I was making parts on a lathe and also on a punch press when I was a teenager," recalled Chris, three of whose brothers continue to work at KMC. Together, along with other family members lending a hand when and where needed, they fashioned parts and equipment to Ken's designs in a three-car garage. "We used to work 12, 14 hours a day if we had to."

In the mid-1970s, the young company relocated from Winnipeg, Canada to Thief River Falls, Minnesota. By the 1980s, manufacturing split off and moved to a site in New Paris, Indiana. By the close of the decade, the company had consolidated its engineering and manufacturing operations to its expanded facility in New Paris.

As the business grew, so did the scope of Chris's roles at the company. "I started doing some of the tool design in the '80s," he said, "and I was doing some of the product design in the '90s." 

A small sampling of HVAC hardware he helped develop include wall-mounted sensors, the proprietary line of KMDigital controllers, the Conquest series of BACnet controllers, and the Company's new Indoor Air Quality line of controllers and measuring devices, not to mention a system for coupling an actuator to a valve or damper, for which he holds a patent.

In his more than five decades in the business, Chris has witnessed firsthand sweeping changes in technology and how it is applied to facility controls. "We went from pneumatics [controls that use compressed air as the signaling medium] to computer electronics on all aspects of a building," he said. "That was the biggest change I've seen." 

In that same time span, KMC Controls has managed to grow while remaining true to its origins as a family-owned business committed to innovation and to the success of its customers.

Today, the original machine shop has given way to a state-of-the-art tool and die facility under the same roof as the engineering department and factory floor. Having all those capabilities in house remains one reason the company can take a concept from drawing to working prototype in a fraction of the time it takes other manufacturers in the controls industry.

Looking ahead, Chris said he looks forward to having more time for his hobbies. "I'll probably do a lot more hunting and fishing," he said. A pilot who has logged more than 4,000 hours in the air, he is also an avid vintage motorcycle collector.

Looking back, said Chris said he enjoys the friendships he's made at KMC. "Good folks here," he said. And he plans to check in on them at KMC from time to time. After all, it's another opportunity take one of his 1930s- and 1940s-era Harley Davidson cruisers out for a ride.

# # #

Media Contact: Jason Mills, (574) 831-8196




Press Release Service by Newswire.com

Original Source: KMC Controls Celebrates Employee's 52 Year Career

Suzie’s CBD Treats Showcases New Products and Booth at SuperZoo 2022

0
Suzie’s CBD Treats Showcases New Products and Booth at SuperZoo 2022

Suzie's CBD at SuperZoo

Suzie's CBD Treats at SuperZoo tradeshow

DENVER - September 6, 2022 - (Newswire.com)

Suzie's CBD treats, a holistic CBD pet product company, returned to Superzoo with a brand-new booth set up and inventive plans for their product line. 

For Suzie's fifth year exhibiting at SuperZoo, the brand moved into a 20x20 booth space and showcased a freshly wrapped delivery van. The setup also included new product displays, branded corner counters, and a patio-style meeting area. 

The Suzie's CBD Treats setup wasn't the only innovative addition brought to Superzoo 2022. The team also brought new products to showcase exclusively before they hit the shelves later this year. 

Attending SuperZoo cements a company like Suzie's CBD Treats place in the industry and allows for unique personal and professional connections with those in attendance. 

"Every year we look forward to being able to share who we are and the quality products we make," says CEO Caleb Gilmore. "We always leave SuperZoo feeling inspired and excited for what lies ahead." 

You can find Suzie's entire lineup of USDA organic, third-party lab-tested CBD products for pets in small and independent retailers across the country as well as on their website. Suziespettreats.com

Press Inquiries

KT Cavanaugh / [email protected]




Press Release Service by Newswire.com

Original Source: Suzie's CBD Treats Showcases New Products and Booth at SuperZoo 2022

Help Dixie Belle Paint Raise Up to $15,000 for the Fight Against Alzheimer’s.

0
Help Dixie Belle Paint Raise Up to ,000 for the Fight Against Alzheimer’s.

Chalk Painted Furniture

Look for our post each day at 1 pm EDT to comment and help us spread the word.

PORT RICHEY, Fla. - September 6, 2022 - (Newswire.com)

Help Dixie Belle Paint raise up to $15,000 for the fight against Alzheimer's. Visit Dixie Belle on Facebook at Dixie Belle Paint Company and look for the "Comment for a Cause" post. Share this with friends and leave a comment. Each post that receives 250 comments and 25 shares generates a $500 donation from Dixie Belle Paint to the Alzheimer's Association. Dixie Belle Paint will post every day at 1 pm EDT throughout the entire month of September.

The Alzheimer's Association defines the disease as a type of dementia that affects memory, thinking, and behavior. Symptoms eventually grow severe enough to interfere with daily tasks. Alzheimer's is a progressive disease, where dementia symptoms gradually worsen over several years. In its preliminary stages, memory loss is mild, but with late-stage Alzheimer's, individuals often lose the ability to carry on a conversation and respond to their environment. On average, a person with Alzheimer's lives 4 to 8 years after diagnosis but can live as long as 20 years, depending on other factors.

Dixie Belle Paint wants to make a difference and you can join the fight. This will cost nothing and can mean everything. Please, visit Dixie Belle Paint Company on Facebook and Comment for a Cause.

For more information on Alzheimer's, please visit the Alzheimer's Association on azl.org and find out other ways to make a difference. For more information or to find your local Dixie Belle Paint Retailer please call us at 813-909-1962 or visit our website at DixieBellePaint.com. Submitted by Teri Ronk, CMO.




Press Release Service by Newswire.com

Original Source: Help Dixie Belle Paint Raise Up to $15,000 for the Fight Against Alzheimer's.

The Argentine Football Association Presents Duelbits as Online Betting Regional Sponsor

0
The Argentine Football Association Presents Duelbits as Online Betting Regional Sponsor
WILLEMSTAD, Curaçao - September 6, 2022 - (Newswire.com)

AFA and Duelbits, the online betting platform, have entered into a commercial agreement for the South American territory (except Argentina), through which the company becomes a Regional Sponsor of the National Teams.

This agreement reinforces the sponsorship platform for national teams, adding a new category and territory to expand the reach of the AFA brand in different South American countries.

Claudio Tapia, President of AFA, highlighted, "In all these years of management, we have developed a strong expansion of the AFA brand, obtaining a global reach. Thanks to this work, we can build agreements with important brands that today find in AFA a strategic partner for their marketing plans, not only in Argentina but in the rest of the continent and the world. We welcome Duelbits to our National Team sponsorship program and wish them every success."

Ross Haffie, Duelbits SportsBook Head, said: "Duelbits is delighted to be an online regional betting sponsor of the Argentine Football Association. This is a landmark deal for us, and we are very excited to work closely with the team over the next 12 months. Also, this is a great year for Argentina, and we want to wish them the best of luck in Qatar."

Leandro Petersen, Commercial Marketing Director of AFA, added: "Today we are pleased to announce this commercial agreement with Duelbits, becoming the first national team to work alongside them. The process of global expansion that we started four years ago grows day by day, increasing the volume of income of our Association and expanding our horizons and our commercial frontiers."

ABOUT DUELBITS

Duelbits.com is a crypto casino and sportsbook aiming to bring users the most rewarding gambling experience. Founded in 2020 and despite the COVID19 crisis, Duelbits has grown into a well-known casino brand, particularly within the crypto niche. Duelbits' ambition is to become a niche global brand, offering users better rewards and an easy-to-use product, all accompanied by the crypto element, allowing users fast and secure payments. They have recently become the "Official European Betting Partner" of Premier League Club Aston Villa and the Official Betting Partner of the biggest South American Esports organisation "Pain Gaming".

Contact: [email protected]




Press Release Service by Newswire.com

Original Source: The Argentine Football Association Presents Duelbits as Online Betting Regional Sponsor

Earlens Shares FDA Historical Ruling on OTC Hearing Aids

0
Earlens Shares FDA Historical Ruling on OTC Hearing Aids
MENLO PARK, Calif. - September 6, 2022 - (Newswire.com)

Earlens, a privately held medical technology company transforming the way people hear with a new class of non-surgical hearing technology, supports the FDA's ruling to create a new category of Over the Counter (OTC) hearing aids. Hearing loss, a medical epidemic associated with dementia, depression and social isolation, affects an estimated 30 million people in the United States. Despite the high prevalence and public health impact of hearing loss, only about one-fifth of people who could benefit from a hearing aid seek intervention.

While this new ruling may address a few of the barriers that impede the adoption of hearing aids, such as perceived hearing benefit relative to price and access, it will not address the top two complaints of hearing aid users: understanding speech in background noise and sound quality. The new over-the-counter hearing aids work in the same way as the traditional hearing aids widely available by prescription today. They amplify sound through a tiny speaker in a limited bandwidth. Unlike traditional hearing aids, Earlens works with the natural hearing system by gently vibrating the eardrum via a tiny, custom-built lens, which delivers 2.5X the audible bandwidth of traditional hearing aids, resulting in significantly better speech understanding in noise and improved clarity. 

"With the changing landscape in the hearing space, Earlens is well positioned to assist the many people that are dissatisfied with traditional air-conduction hearing aids, whether they are purchased in a store, through a dispenser, or over the counter. Earlens' differentiated technology and unique care model places highly trained hearing healthcare professionals at the forefront of hearing loss treatment. Earlens is committed to transforming the hearing experience for millions of people who suffer from hearing loss", said Bill Facteau, Earlens President & Chief Executive Officer.

About Earlens

Earlens is a privately held medical technology company that has developed the Earlens® hearing solution. With more than 185 US and international patents, Earlens was named to Time Magazine's list of the top 100 inventions of 2020. Earlens is exclusively available from a growing network of highly trained Ear, Nose & Throat physicians and audiologists who are supported by a dedicated concierge team. For more information, please visit www.earlens.com.

Contact

Connon Samuel

Chief Operating Officer

1-844-234-LENS (5367)




Press Release Service by Newswire.com

Original Source: Earlens Shares FDA Historical Ruling on OTC Hearing Aids

Kerr Dental’s Nexus™ RMGI Offers Smart Response Ion Technology to Help Prevent Secondary Caries

0
Kerr Dental’s Nexus™ RMGI Offers Smart Response Ion Technology to Help Prevent Secondary Caries
Featuring the Smart Response Ion Technology, Nexus™ RMGI has been proven to offer a sustained ion release that helps prevent secondary caries.

BREA, Calif. - September 6, 2022 - (Newswire.com)

Kerr Dental announces the relaunch of Nexus RMGI, a resin-modified glass ionomer luting cement featuring Smart Response Ion Technology. The first RMGI available with advanced NexusTM Technology, Nexus RMGI is formulated for easy cleanup, outstanding bond strength, great color stability, and provides sustained ion release to help prevent secondary caries.

Since its original launch in 2013, NexusTM RMGI has been known for its proprietary One-Peel™ Cleanup that simplifies cleanup during the luting process - making it the cement of choice for many dental professionals. Kerr Dental customers will be pleased to learn that in addition to being easier to use, recent studies have shown that the NexusTM RMGI also offers sustained ion release that can help prevent secondary caries. 

Featuring Kerr's Smart Response Ion Technology, the NexusTM RMGI is formulated for a sustained release of fluoride, as well as calcium and zinc in acidic environments, thus providing antibacterial properties to help prevent secondary caries.

Lea Pagaduan, Senior Marketing Manager at Kerr Dental, says, "Doctors want to have confidence that an RMGI will continue to perform well after restoration placement. The Smart Response Ion Technology gives doctors that confidence, making Nexus RMGI the cement of choice to help protect against secondary caries." 

Pagaduan continued, "NexusTM RMGI also features easy clean-up and a dual-adhesive system that provides 50-80% greater bond strength relative to other leading brands for metal and zirconia crowns." 

Features like Smart Response Ion Technology, One-Peel Cleanup, and the highest bond strength combined in Nexus RMGI provide doctors with a luting cement that helps them work faster and with greater confidence in the outcomes.

To learn more about Nexus RMGI's One-Peel Cleanup, outstanding bond strength, and Smart Response Ion Technology, visit kerrdental.com.

For Further Information

[email protected]

Kerr Dental

200 S. Kraemer Blvd., Building E

Brea, CA 92821

Telephone: (949) 294-6251




Press Release Service by Newswire.com

Original Source: Kerr Dental's Nexus™ RMGI Offers Smart Response Ion Technology to Help Prevent Secondary Caries